Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease

Ageing Research Reviews

Volumn 11, Issue 1, 2012, Pages 87-103

  Panza, Francesco ^a   Frisardi, Vincenza ^b   Seripa, Davide ^a   D'Onofrio, Grazia ^a   Santamato, Andrea ^c   Masullo, Carlo ^d   Logroscino, Giancarlo ^b   Solfrizzi, Vincenzo ^b   Pilotto, Alberto ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alzheimer's disease; APOE; Apolipoprotein E; Dementia; Neuropsychiatric symptoms; Neuropsychiatric syndromes

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

AGGRESSION; AGITATION; ALLELE; ALZHEIMER DISEASE; ANXIETY DISORDER; APATHY; COGNITIVE DEFECT; DELUSION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMOTIONAL STRESS; ENDOPHENOTYPE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HALLUCINATION; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; NEUROPSYCHIATRIC SYMPTOM; NEUROPSYCHIATRY; PSYCHOSIS; REVIEW;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; SYNDROME;

EID: 83855165791     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2011.06.005     Document Type: Review

References (179)

1. Aalten P., de Vugt M.E., Lousberg R., Korten E., Jaspers N., Senden B., Jolles J., Verhey F.R. Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement. Geriatr. Cogn. Disord. 2003, 15:99-105.
2. Aalten P., Verhey F.R., Boziki M., Bullock R., Byrne E.J., Camus V., Caputo M., Collins D., De Deyn P.P., Elina K., Frisoni G., Girtler N., Holmes C., Hurt C., Marriott A., Mecocci P., Nobili F., Ousset P.J., Reynish E., Salmon E., Tsolaki M., Vellas B., Robert P.H. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement. Geriatr. Cogn. Disord. 2007, 24:457-463.
3. Aalten P., Verhey F.R., Boziki M., Brugnolo A., Bullock R., Byrne E.J., Camus V., Caputo M., Collins D., De Deyn P.P., Elina K., Frisoni G., Holmes C., Hurt C., Marriott A., Mecocci P., Nobili F., Ousset P.J., Reynish E., Salmon E., Tsolaki M., Vellas B., Robert P.H. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium: part II. Dement. Geriatr. Cogn. Disord. 2008, 25:1-8.
4. Aharon-Peretz J., Kliot D., Tomer R. Behavioral differences between white matter lacunar dementia and Alzheimer's disease: a comparison on the neuropsychiatric inventory. Dement. Geriatr. Cogn. Disord. 2000, 11:294-298.
5. Alexopoulos G.S., Meyers B.S., Young R.C., Kakuma T., Silbersweig D., Charlson M. Clinically defined vascular depression. Am. J. Psychiatry 1997, 154:562-565.
6. Alexopoulos G.S. Depression in the elderly. Lancet 2005, 365:1961-1970.
7. Alexopoulos G.S., Schultz S.K., Lebowitz B.D. Late-life depression: a model for medical classification. Biol. Psychiatry 2005, 58:283-289.
8. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement. 2010, 6:158-194.
9. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2004, American Psychiatric Publishing, Inc., Arlington, VA. fourth edition.
10. Arendt T., Schindler C., Brückner M.K., Eschrich K., Bigl V., Zedlick D., Marcova L. Plastic neuronal remodelling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J. Neurosci. 1997, 17:516-529.
11. Bacanu S.A., Devlin B., Chowdari K.V., DeKosky S.T., Nimgaonkar V.L., Sweet R.A. Heritability of psychosis in Alzheimer disease. Am. J. Geriatr. Psychiatry 2005, 13:624-627.
12. Ballard C., Massey H., Lamb H., Morris C. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1997, 63:273.
13. Ballard C., Neill D., O'Brien J., McKeith I.G., Ince P., Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J. Affect. Disord. 2000, 59:97-106.
14. Basso M., Gelernter J., Yang J., MacAvoy M.G., Varma P., Bronen R.A., van Dyck C.H. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease. Neurobiol. Aging 2006, 27:1416-1424.
15. Bathgate D., Snowden J.S., Varma A., Blackshaw A., Neary D. Behaviour in frontotemporal dementia. Alzheimer's disease and vascular dementia. Acta Neurol. Scand. 2001, 103:367-378.
16. Beaudreau S.A., O'Hara R. Late-life anxiety and cognitive impairment: a review. Am. J. Geriatr. Psychiatry 2008, 16:790-803.
17. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39:17-23.
18. Borroni B., Grassi M., Agosti C., Costanzi C., Archetti S., Franzoni S., Caltagirone C., Di Luca M., Caimi L., Padovani A. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol. Aging 2006, 27:1595-1603.
19. Borroni B., Costanzi C., Padovani A. Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease. Curr. Alzheimer Res. 2010, 7:158-164.
20. Boyle P.A., Malloy P.F. Treating apathy in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2004, 17:91-99.
21. Brscic E., Bergerone S., Gagnor A., Colajanni E., Matullo G., Scaglione L., Cassader M., Gaschino G., Di Leo M., Brusca A., Pagano G.F., Piazza A., Trevi G.P. Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme angiotensin II type I receptor apolipoprotein E endothelial constitutive nitric oxide synthase and glycoprotein IIIa genetic polymorphisms at medium-term follow-up. Am. Heart J. 2000, 139:979-984.
22. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007, 3:186-191.
23. Cacabelos R., Rodríguez B., Carrera C., Caamaño J., Beyer K., Lao J.I., Sellers M.A. APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find. Exp. Clin. Pharmacol. 1996, 18:693-706.
24. Cacabelos R., Rodríguez B., Carrera C., Beyer K., Lao J.I., Sellers M.A. Behavioral changes associated with different apolipoprotein E genotypes in dementia. Alzheimer Dis. Assoc. Disord. 1997, 11(Suppl. 4):S27-S34.
25. Cantillon M., Harwood D., Barker W., St George-Hyslop P., Tsuda T., Ekatarina R., Duara R. No association between apolipoprotein E genotype and late-onset depression in Alzheimer's disease. Biol. Psychiatry 1997, 41:246-248.
26. Carrasquillo M.M., Zou F., Pankratz V.S., Wilcox S.L., Ma L., Walker L.P., Younkin S.G., Younkin C.S., Younkin L.H., Bisceglio G.D., Ertekin-Taner N., Crook J.E., Dickson D.W., Petersen R.C., Graff-Radford N.R., Younkin S.G. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nat. Genet. 2009, 41:192-198.
27. Chang J.B., Wang P.N., Chen W.T., Liu C.Y., Hong C.J., Lin K.N., Liu T.Y., Chi C.W., Liu H.C. ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD. Neurology 2004, 63:1105-1107.
28. Chen S., Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J. Clin. Oncol. 2007, 25:1329-1333.
29. Chopra M.P., Landes R.D., Jones R.A., Feldman Z.L., Beck C., Griffin S.T. Does the apolipoprotein E epsilon 4 genotype influence the expression of depression with cognitive impairment?. Int. J. Geriatr. Psychiatry 2009, 24:650-652.
30. Cohen-Mansfield J. Nonpharmacologic interventions for inappropriate behaviors in dementia: a review and critique. Am. J. Geriatr. Psychiatry 2001, 9:361-381.
31. Cohen-Mansfield L., Werner P. Longitudinal predictors of nonaggressive behaviors in the elderly. Int. J. Geriatr. Psychiatry 1999, 14:831-844.
32. Craig A.H., Cummings J.L., Fairbanks L., Itti L., Miller B.L., Li J., Mena I. Cerebral blood flow correlates of apathy in Alzheimer disease. Arch. Neurol. 1996, 53:1116-1120.
33. Craig D., Hart D.J., McCool K., McIlroy S.P., Passmore A.P. Apolipoprotein E e{open}4 allele influences aggressive behaviour in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2004, 75:1327-1330.
34. Craig D., Hart D.J., McIlroy S.P., Passmore A.P. Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2005, 19:154-157.
35. Crawford F.C., Vanderploeg R.D., Freeman M.J., Singh S., Waisman M., Michaels L. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 2002, 58:1115-1118.
36. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308-2314.
37. Cummings J.L., Kaufer D. Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996, 47:876-883.
38. Cummings J.L. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol. Aging 2000, 21:845-861.
39. Davignon J., Cohn J.S., Mabile L., Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin. Chim. Acta 1999, 286:115-143.
40. Delano-Wood L., Houston W.S., Emond J.A., Marchant N.L., Salmon D.P., Jeste D.V., Thal L.J., Bondi M.W. APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study. Int. J. Geriatr. Psychiatry 2008, 23:632-636.
41. Del Prete M., Spaccavento S., Craca A., Fiore P., Angelelli P. Neuropsychiatric symptoms and the APOE genotype in Alzheimer's disease. Neurol. Sci. 2009, 30:367-373.
42. Del Ser T., McKeith I., Anand R., Cicin-Sain A., Ferrara R., Spiegel R. Dementia with Lewy bodies: findings from an international multicentre study. Int. J. Geriatr. Psychiatry 2000, 15:1034-1045.
43. de Leeuw F.E., Richard F., de Groot J.C., van Duijn C.M., Hofman A., Van Gijn J., Breteler M.M. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 2004, 35:1057-1060.
44. DeMichele-Sweet M.A., Sweet R.A. Genetics of psychosis in Alzheimer's disease: a review. J. Alzheimers Dis. 2010, 7:158-164.
45. Deutsch L.H., Bylsma F.W., Rovner B.W., Steele C., Folstein M.F. Psychosis and physical aggression in probable Alzheimer's disease. Am. J. Psychiatry 1991, 148:1159-1163.
46. D'Onofrio, G., Sancarlo, D., Panza, F., Copetti, M., Cascavilla, L., Paris, F., Seripa, D., Matera, M.G., Solfrizzi, V., Pellegrini, F., Pilotto, A., 2010a. Neuropsychiatric symptoms in patients with Alzheimer's disease and vascular dementia. Curr. Alzheimer Res., in press.
47. D'Onofrio, G., Panza, F., Seripa, D., Sancarlo, D., Paris, F., Cascavilla, L., Urbano, M., Gravina, C., Fontana, A., Solfrizzi, V., Pellegrini, F., Pilotto, A., 2010b. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes. Int. J. Geriatr. Psychiatry, (epub ahead of print). doi:10.1002/gps.2644.
48. Engelborghs S., Dermaut B., Marien P., Symons A., Vloeberghs E., Maertens K., Somers N., Goeman J., Rademakers R., Van den Broeck M., Pickut B., Cruts M., Van Broeckhoven C., De Deyn P.P. Dose dependent effect of APOE e4 on behavioral symptoms in frontal lobe dementia. Neurobiol. Aging 2006, 27:285-292.
49. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997, 278:1349-1356.
50. Fernández-Martínez M., Castro J., Molano A., Zarranz J.J., Rodrigo R.M., Ortega R. Prevalence of neuropsychiatric symptoms in Alzheimer's disease and vascular dementia. Curr. Alzheimer Res. 2008, 5:61-69.
51. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117. Alzheimer's Disease International.
52. Finkel S.I., Costa e Silva J., Cohen G., Miller S., Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int. Psychogeriatr. 1996, 8(Suppl. 3):497-500.
53. Forsell Y., Corder E.H., Basun H., Lannfelt L., Viitanen M., Winblad B. Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Biol. Psychiatry 1997, 42:898-903.
54. Forsell Y., Basun H., Corder E.H., Lannfelt L., Winblad B. Psychotic symptoms and apolipoprotein E genotypes in an elderly population. Biol. Psychiatry 1998, 44:139-140.
55. Forstl H., Burns A., Levy R., Cairns N. Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease. Br. J. Psychiatry 1994, 165:53-59.
56. Fuh J.L., Wang S.J., Cummings J.L. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J. Neurol. Neurosurg. Psychiatry 2005, 76:1337-1341.
57. Gabryelewicz T., Religa D., Styczynska M., Peplonska B., Pfeffer A., Wasiak B., Luczywek E., Golebiowski M., Androsiuk W., Czyzewski K., Przekop I., Barcikowska M. Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dement. Geriatr. Cogn. Disord. 2002, 14:208-212.
58. Gauthier S., Cummings J., Ballard C., Brodaty H., Grossberg G., Robert P., Lyketsos C. Management of behavioral problems in Alzheimer's disease. Int. Psychogeriatr. 2010, 22:346-372.
59. Geda Y.E., Knopman D.S., Mrazek D.A., Jicha G.A., Smith G.E., Negash S., Boeve B.F., Ivnik R.J., Petersen R.C., Pankratz V.S., Rocca W.A. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch. Neurol. 2006, 63:435-440.
60. Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M.J., Engelborghs, S., De Deyn, P., Berr, C., Pasquier, F., Dubois, B., Tognoni, G., Fiévet, N., Brouwers, N., Bettens, K., Arosio, B., Coto, E., Del Zompo, M., Mateo, I., Epelbaum, J., Frank-Garcia, A., Helisalmi, S., Porcellini, E., Pilotto, A., Forti, P., Ferri, R., Scarpini, E., Siciliano, G., Solfrizzi, V., Sorbi, S., Spalletta, G., Valdivieso, F., Vepsäläinen, S., Alvarez, V., Bosco, P., Mancuso, M., Panza, F., Nacmias, B., Bossù, P., Hanon, O., Piccardi, P., Annoni, G., Seripa, D., Galimberti, D., Licastro, F., Soininen, H., Dartigues, J.F., Kamboh, M.I., Van Broeckhoven, C., Lambert, J.C., Amouyel, P., Campion, D., 2011. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry, (epub ahead of print). doi:10.1038/mp.2011.52.
61. Gomez-Isla T., West H.L., Rebeck G.W., Harr S.D., Growdon J.H., Locascio J.J., Perls T.T., Lipsitz L.A., Hyman B.T. Clinical and pathological correlates of apolipoprotein E e4 in Alzheimer's disease. Ann. Neurol. 1996, 39:62-70.
62. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schürmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Hüll M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
63. Harwood D.G., Barker W.W., Ownby R.L., St George-Hyslop P., Duara R. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am. J. Geriatr. Psychiatry 1999, 7:119-123.
64. Hashimoto M., Yasuda M., Tanimukai S., Matsui M., Hirono N., Kazui H., Mori E. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 2001, 57:1461-1466.
65. Herrmann N., Lanctôt K.L., Sambrook R., Lesnikova N., Hébert R., McCracken P., Robillard A., Nguyen E. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int. J. Geriatr. Psychiatry 2006, 21:972-976.
66. Hippisley-Cox J., Pringle M., Crown N., Meal A., Wynn A. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 2001, 322:832-835.
67. Hirono N., Mori E., Yasuda M., Ikejiri Y., Imamura T., Shimomura T., Ikeda M., Hashimoto M., Yamashita H. Factors associated with psychotic symptoms in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1998, 64:648-652.
68. Hirono N., Mori E., Yasuda M., Imamura T., Shimomura T., Hashimoto M., Tanimukai S., Kazui H., Yamashita H. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease. J. Neuropsychiatry Clin. Neurosci. 1999, 11:66-70.
69. Hirono N., Mega M.S., Dinov I.D., Mishkin F., Cummings J.L. Left frontotemporal hypoperfusion is associated with aggression in patients with dementia. Arch. Neurol. 2000, 57:861-866.
70. Hollingworth P., Hamshere M.L., Moskvina V., Dowzell K., Moore P.J., Foy C., Archer N., Lynch A., Lovestone S., Brayne C., Rubinsztein D.C., Lawlor B., Gill M., Owen M.J., Williams J. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. J. Am. Geriatr. Soc. 2006, 54:1348-1354.
71. Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J.C., Carrasquillo, M.M., Abraham, R., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Jones, N., Stretton, A., Thomas, C., Richards, A., Ivanov, D., Widdowson, C., Chapman, J., Lovestone, S., Powell, J., Proitsi, P., Lupton, M.K., Brayne, C., Rubinsztein, D.C., Gill, M., Lawlor, B., Lynch, A., Brown, K.S., Passmore, P.A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A.D., Beaumont, H., Warden, D., Wilcock, G., Love, S., Kehoe, P.G., Hooper, N.M., Vardy, E.R., Hardy, J., Mead, S., Fox, N.C., Rossor, M., Collinge, J., Maier, W., Jessen, F., Rüther, E., Schürmann, B., Heun, R., Kölsch, H., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frölich, L., Hampel, H., Gallacher, J., Hüll, M., Rujescu, D., Giegling, I., Goate, A.M., Kauwe, J.S., Cruchaga, C., Nowotny, P., Morris, J.C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C., Livingston, G., Bass, N.J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C.E., Tsolaki, M., Singleton, A.B., Guerreiro, R., Mühleisen, T.W., Nöthen, M.M., Moebus, S., Jöckel, K.H., Klopp, N., Wichmann, H.E., Pankratz, V.S., Sando, S.B., Aasly, J.O., Barcikowska, M., Wszolek, Z.K., Dickson, D.W., Graff-Radford, N.R., Petersen, R.C., the Alzheimer's Disease Neuroimaging Initiative, van Duijn, C.M., Breteler, M.M., Ikram, M.A., Destefano, A.L., Fitzpatrick, A.L., Lopez, O., Launer, L.J., Seshadri, S., CHARGE Consortium, Berr, C., Campion, D., Epelbaum, J., Dartigues, J.F., Tzourio, C., Alpérovitch, A., Lathrop, M., EADI1 Consortium, Feulner, T.M., Friedrich, P., Riehle, C., Krawczak, M., Schreiber, S., Mayhaus, M., Nicolhaus, S., Wagenpfeil, S., Steinberg, S., Stefansson, H., Stefansson, K., Snædal, J., Björnsson, S., Jonsson, P.V., Chouraki, V., Genier-Boley, B., Hiltunen, M., Soininen, H., Combarros, O., Zelenika, D., Delepine, M., Bullido, M.J., Pasquier, F., Mateo, I., Frank-Garcia, A., Porcellini, E., Hanon, O., Coto, E., Alvarez, V., Bosco, P., Siciliano, G., Mancuso, M., Panza, F., Solfrizzi, V., Nacmias, B., Sorbi, S., Bossù, P., Piccardi, P., Arosio, B., Annoni, G., Seripa, D., Pilotto, A., Scarpini, E,. Galimberti, D., Brice, A., Hannequin, D., Licastro, F., Jones, L., Holmans, P.A., Jonsson, T., Riemenschneider, M., Morgan, K., Younkin, S.G., Owen, M.J., O'Donovan, M., Amouyel, P., Williams, J., 2011. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43, 429-435.
72. Holmes C., Levy R., McLoughlin D.M., Powell J.F., Lovestone S. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1996, 61:580-583.
73. Holmes C., McLoughlin D.M., Powell J., Lovestone S. Reply. J. Neurol. Neurosurg. Psychiatry 1997, 63:273-274.
74. Holmes C., Russ C., Kirov G., Aitchison K.J., Powell J.F., Collier D.A., Lovestone S. Apolipoprotein E: depressive illness, depressive symptoms and Alzheimer's disease. Biol. Psychiatry 1998, 43:159-164.
75. Holthoff V.A., Beuthien-Baumann B., Kalbe E., Lüdecke S., Lenz O., Zündorf G., Spirling S., Schierz K., Winiecki P., Sorbi S., Herholz K. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol. Psychiatry 2005, 57:412-421.
76. Ikeda M., Fukuhara R., Shigenobu K., Hokoishi K., Maki N., Nebu A., Komori K., Tanabe H. Dementia associated mental and behavioral disturbances in elderly people in the community: finding from the first Nakayama study. J. Neurol. Neurosurg. Psychiatry 2004, 75:146-148.
77. Irie F., Masaki K.H., Petrovitch H., Abbott R.D., Ross G.W., Taaffe D.R., Launer L.J., White L.R. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. Arch. Gen. Psychiatry 2008, 65:906-912.
78. Ishii S., Weintraub N., Mervis J.R. Apathy: a common psychiatric syndrome in the elderly. J. Am. Med. Dir. Assoc. 2009, 10:381-393.
79. Jeste D.V., Finkel S.I. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am. J. Geriatr. Psychiatry 2000, 8:29-34.
80. Jeste D.V., Meeks T.W., Kim D.S., Zubenko G.S. Research agenda for DSM-V: diagnostic categories and criteria for neuropsychiatric syndromes in dementia. J. Geriatr. Psychiatry Neurol. 2006, 19:160-171.
81. Kanai M., Shizuka M., Urakami K., Matsubara E., Harigaya Y., Okamoto K., Shoji M. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease. Neurosci. Lett. 1999, 267:65-68.
82. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
83. Kim J.M., Lyons D., Shin I.S., Yoon J.S. Differences in behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?. Hum. Psychopharmacol. 2003, 18:215-220.
84. Kim J.M., Kim S.Y., Bae K.Y., Kim S.W., Shin I.S., Yang S.J., Song Y.H., Yoon J.S. Apolipoprotein e4 genotype and depressive symptoms as risk factors for dementia in an older korean population. Psychiatry Investig. 2010, 7:135-140.
85. Krishnan K.R., Tupler L.A., Ritchie J.C., McDonald W.M., Knight D.L., Nemeroff C.B., Carroll B.J. Apolipoprotein E-e{open}4 frequency in geriatric depression. Biol. Psychiatry 1996, 40:69-71.
86. Lambert, J.C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M.J., Tavernier, B., Letenneur, L., Bettens, K., Berr, C., Pasquier, F., Fiévet, N., Barberger-Gateau, P., Engelborghs, S., De Deyn, P., Mateo, I., Franck, A., Helisalmi, S., Porcellini, E., Hanon, O., European Alzheimer's Disease Initiative Investigators, de Pancorbo, M.M., Lendon, C., Dufouil, C., Jaillard, C., Leveillard, T., Alvarez, V., Bosco, P., Mancuso, M., Panza, F., Nacmias, B., Bossù, P., Piccardi, P., Annoni, G., Seripa, D., Galimberti, D., Hannequin, D., Licastro, F., Soininen, H., Ritchie, K., Blanché, H., Dartigues, J.F., Tzourio, C., Gut, I., Van Broeckhoven, C., Alpérovitch, A., Lathrop, M., Amouyel, P., 2009. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094-1099.
87. Landes A.M., Sperry S.D., Strauss M.E., Geldmacher D.S. Apathy in Alzheimer's disease. J. Am. Geriatr. Soc. 2001, 49:1700-1707.
88. Lawlor B. Serotonin and Alzheimer's disease. Psychiatric Ann. 1990, 20:567-570.
89. Lee K.U., Lee J.S., Kim K.W., Jhoo J.H., Lee D.Y., Yoon J.C., Lee J.H., Lee D.S., Lee M.C., Woo J.I. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients. J. Neuropsychiatry Clin. Neurosci. 2003, 15:78-83.
90. Lehtovirta M., Soininen H., Helisalmi S., Mannermaa A., Helkala E.L., Hartikainen P., Hänninen T., Ryynänen M., Riekkinen P.J. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996, 46:413-419.
91. Lehtovirta M., Soininen H., Laakso M.P., Partanen K., Helisalmi S., Mannermaa A., Ryynänen M., Kuikka J., Hartikainen P., Riekkinen P.J. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E e4 allele. J. Neurol. Neurosurg. Psychiatry 1996, 60:644-649.
92. Levy M.L., Miller B.L., Cummings J.L., Fairbanks L.A., Craig A. Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch. Neurol. 1996, 53:687-690.
93. Levy M.L., Cummings J.L., Fairbanks L.A., Masterman D., Miller B.L., Craig A.H., Paulsen J.S., Litvan I. Apathy is not depression. J. Neuropsychiatry Clin. Neurosci. 1998, 10:314-319.
94. Levy M.L., Cummings J.L., Fairbanks L.A., Sultzer D.L., Small G.W. Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biol. Psychiatry 1999, 45:422-425.
95. Letenneur L., Gilleron V., Commenges D., Helmer C., Orgogozo J.M., Dartigues J.F. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J. Neurol. Neurosurg. Psychiatry 1999, 66:177-183.
96. Liu C.Y., Hong C.J., Liu T.Y., Lin K.N., Wang P.N., Chi C.W., Chuang Y.Y., Liu H.C. Lack of association between the ApoE genotype and depression in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 2002, 15:20-23.
97. Looi J.C., Sachdev P.S. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999, 53:670-678.
98. Lopez O.L., Kamboh M.I., Becker J.T., Kaufer D.I., Dekosky S.T. The apolipoprotein E epsilon 4 allele is not associated with psychotic symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997, 49:794-797.
99. López-León S., Janssens A.C., González-Zuloeta Ladd A.M., Del-Favero J., Claes S.J., Oostra B.A., van Duijn C.M. Meta-analyses of genetic studies on major depressive disorder. Mol. Psychiatry 2008, 13:772-785.
100. Lyketsos C.G., Baker L., Warren A., Steele C., Brandt J., Steinberg M., Kopunek S., Baker A. Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. J. Neuropsychiatry Clin. Neurosci. 1997, 9:64-67.
101. Lyketsos C.G., Steinberg M., Tschanz J.T., Norton M.C., Steffens D.C., Breitner J.C. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am. J. Psychiatry 2000, 157:708-714.
102. Lyketsos C.G., Lopez O., Jones B., Fitzpatrick A.L., Breitner J., DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002, 288:1475-1483.
103. Marin R.S. Apathy: a neuropsychiatric syndrome. J. Neuropsychiatry Clin. Neurosci. 1991, 3:243-254.
104. Mayeux R. Epidemiology of neurodegeneration. Annu. Rev. Neurosci. 2003, 26:81-104.
105. McCarron M.O., Delong D., Alberts M.J. APOE genotype as a risk factor for ischemic cerebrovascular disease. Neurology 1999, 53:1308-1311.
106. McNamara M.J., Gomez-Isla T., Hyman B.T. Apolipoprotein E genotype and deposits of Ab40 and Ab42 in Alzheimer disease. Arch. Neurol. 1998, 55:1001-1004.
107. McPherson S., Fairbanks L., Tiken S., Cummings J.L., Back-Madruga C. Apathy and executive function in Alzheimer's disease. J. Int. Neuropsychol. Soc. 2002, 8:373-381.
108. Mega M.S., Cummings J.L., Fiorello T., Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996, 46:130-135.
109. Michikawa M., Fan Q.W., Isobe I., Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J. Neurochem. 2000, 74:1008-1016.
110. Migneco O., Benoit M., Koulibaly P.M., Dygai I., Bertogliati C., Desvignes P., Robert P.H., Malandain G., Bussiere F., Darcourt J. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer's disease and nondemented patients. Neuroimage 2001, 13:896-902.
111. Mintzer J.E., Brawman-Mintzer O. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J. Clin. Psychiatry 1996, 57(Suppl. 7):55-63.
112. Monastero R., Mariani E., Camarda C., Ingegni T., Averna M.R., Senin U., Camarda R., Mecocci P. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Acta Psychiatr. Scand. 2006, 3:59-63.
113. Murman D.L., Chen Q., Powell M.C., Kuo S.B., Bradley C.J., Colenda C.C. The incremental direct costs associated with behavioral symptoms in AD. Neurology 2002, 59:1721-1729.
114. Müller-Thomsen T., Arlt S., Ganzer S., Mann U., Mass R., Naber D., Beisiegel U. Depression in Alzheimer's disease might be associated with apolipoprotein E e4 allele: frequency in women but not in men. Dement. Geriatr. Cogn. Disord. 2002, 14:59-63.
115. Murphy G.M., Taylor J., Tinklenberg J.R., Yesavage J.A. The apolipoprotein E epsilon 4 allele is associated with increased behavioral disturbance in Alzheimer's disease. Am. J. Geriatr. Psychiatry 1997, 5:88-89.
116. Murrell J.R., Price B.M., Baiyewu O., Gureje O., Deeg M., Hendrie H., Ogunniyi A., Hall K. The fourth apolipoprotein E haplotype found in the Yoruba of Ibadan. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006, 141B:426-427.
117. Nacmias B., Tedde A., Forleo P., Piacentini S., Guarnieri B.M., Bartoli A., Ortenzi L., Petruzzi C., Serio A., Marcon G., Sorbi S. Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease. Biol. Psychiatry 2001, 50:472-475.
118. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., George-Hyslop P.S., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., Decarli C., Dekosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441.
119. Nyatsanza S., Shetty T., Gregory C., Lough S., Dawson K., Hodges J.R. A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 2003, 74:1398-1402.
120. O'Brien J., Perry R., Barber R., Gholkar A., Thomas A. The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Ann. N. Y. Acad. Sci. 2000, 903:482-489.
121. Okiishi C.G., Paradiso S., Robinson R.G. Gender differences in depression associated with neurologic illness: clinical correlates and pharmacological response. J. Gender Specific Med. 2001, 4:65-72.
122. Panza F., D'Introno A., Colacicco A.M., Capurso C., Del Parigi A., Capurso S.A., Caselli R.J., Pilotto A., Scafato E., Capurso A., Solfrizzi V. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol. Aging 2005, 27:933-940.
123. Panza F., Frisardi V., Capurso C., D'Introno A., Colacicco A.M., Imbimbo B.P., Santamato A., Vendemiale G., Seripa D., Pilotto A., Capurso A., Solfrizzi V. Late-life depression, mild cognitive impairment, and dementia: possible continuum?. Am. J. Geriatr. Psychiatry 2010, 18:98-116.
124. Persico A.M., D'Agruma L., Zelante L., Militerni R., Bravaccio C., Schneider C., Melmed R., Trillo S., Montecchi F., Elia M., Palermo M., Rabinowitz D., Pascucci T., Puglisi-Allegra S., Reichelt K.L., Muscarella L., Guarnieri V., Melgari J.M., Conciatori M., Keller F. Enhanced APOE2 transmission rates in families with autistic probands. Psychiatr. Genet. 2004, 14:73-82.
125. Poirier J., Delisle M.C., Quirion R., Aubert I., Farlow M., Lahiri D., Hui S., Bertrand P., Nalbantoglu J., Gilfix B.M., Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:12260-12264.
126. Porter V.R., Buxton W.G., Fairbanks L.A., Strickland T., O'Connor S.M., Rosenberg-Thompson S., Cummings J.L. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J. Neuropsychiatry Clin. Neurosci. 2003, 15:180-186.
127. Potter G.G., Steffens D.C. Contribution of depression to cognitive impairment and dementia in older adults. Neurologist 2007, 13:105-117.
128. Pritchard A.L., Harris J., Pritchard C.W., Coates J., Haque S., Holder R., Bentham P., Lendon C.L. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:123-126.
129. Raber J. Role of apolipoprotein E in anxiety. Neural. Plast. 2007, 2007:91236.
130. Ramachandran G., Marder K., Tang M., Schofield P.W., Chun M.R., Devanand D.P., Stern Y., Mayeux R. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996, 47:256-259.
131. Regier D.A., Boyd J.H., Burke J.D., Rae D.S., Myers J.K., Kramer M., Robins L.N., George L.K., Karno M., Locke B.Z. One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch. Gen. Psychiatry 1988, 45:977-986.
132. Reiman E.M., Webster J.A., Myers A.J., Hardy J., Dunckley T., Zismann V.L., Joshipura K.D., Pearson J.V., Hu-Lince D., Huentelman M.J., Craig D.W., Coon K.D., Liang W.S., Herbert R.H., Beach T., Rohrer K.C., Zhao A.S., Leung D., Bryden L., Marlowe L., Kaleem M., Mastroeni D., Grover A., Heward C.B., Ravid R., Rogers J., Hutton M.L., Melquist S., Petersen R.C., Alexander G.E., Caselli R.J., Kukull W., Papassotiropoulos A., Stephan D.A. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007, 54:713-720.
133. Reinikainen K.J., Soininen H., Reikkinen P.J. Neurotransmitter changes in Alzheimer's dementia and agitation. J. Neurosci. Res. 1990, 27:576-586.
134. Reisberg B., Auer S.R., Monteiro I.M. Behavioral pathology in Alzheimer's Disease (BEHAVE-AD) Rating Scale. Int. Psychogeriatr. 1996, 8(Suppl. 3):301-308.
135. Reitz C., Mayeux R. Endophenotypes in normal brain morphology and Alzheimer's disease: a review. Neuroscience 2009, 164:174-190.
136. Rigaud A.S., Traykov L., Caputo L., Coste J., Latour F., Couderc R., Moulin F., Boller F., Forette F. Association of the apolipoprotein E 4 allele with late-onset depression. Neuroepidemiology 2001, 20:268-272.
137. Robertson J., Curley J., Kaye J., Quinn J., Pfankuch T., Raber J. APOE isoforms and measures of anxiety in probable AD patients and apoe -/- mice. Neurobiol. Aging 2005, 26:637-643.
138. Rocca W.A., Cha R.H., Waring S.C., Kokmen E. Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am. J. Epidemiol. 1998, 148:51-62.
139. Ropacki S.A., Jeste D.V. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am. J. Psychiatr. 2005, 162:160-171.
140. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
141. Sawada H., Udaka F., Izumi Y., Nishinaka K., Kawakami H., Nakamura S., Kameyama M. Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2000, 68:653-656.
142. Scarmeas N., Brandt J., Albert M., Devanand D.P., Marder K., Bell K., Ciappa A., Tycko B., Stern Y. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology 2002, 58:1182-1188.
143. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid β-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9649-9653.
144. Seignourel P.J., Kunik M.E., Snow L., Wilson N., Stanley M. Anxiety in dementia: a critical review. Clin. Psychol. Rev. 2008, 28:1071-1082.
145. Seripa D., Matera M.G., Daniele A., Bizzarro A., Rinaldi M., Gravina C., Bisceglia L., Corbo R.M., Panza F., Solfrizzi V., Fazio V.M., Forno G.D., Masullo C., Dallapiccola B., Pilotto A. The missing ApoE allele. Ann. Hum. Genet. 2007, 71:496-500.
146. Seripa D., Panza F., Franceschi M., D'Onofrio G., Solfrizzi V., Dallapiccola B., Pilotto A. Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease. Ageing Res. Rev. 2009, 8:214-236.
147. Seripa, D., D'Onofrio, G., Panza, F., Cascavilla, L., Masullo, C., Pilotto, A., 2011. The genetics of the human APOE polymorphism. Rejuvenation Res., in press.
148. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., Harold D., Schrijvers E.M., Ramirez-Lorca R., Debette S., Longstreth W.T., Janssens A.C., Pankratz V.S., Dartigues J.F., Hollingworth P., Aspelund T., Hernandez I., Beiser A., Kuller L.H., Koudstaal P.J., Dickson D.W., Tzourio C., Abraham R., Antunez C., Du Y., Rotter J.I., Aulchenko Y.S., Harris T.B., Petersen R.C., Berr C., Owen M.J., Lopez-Arrieta J., Varadarajan B.N., Becker J.T., Rivadeneira F., Nalls M.A., Graff-Radford N.R., Campion D., Auerbach S., Rice K., Hofman A., Jonsson P.V., Schmidt H., Lathrop M., Mosley T.H., Au R., Psaty B.M., Uitterlinden A.G., Farrer L.A., Lumley T., Ruiz A., Williams J., Amouyel P., Younkin S.G., Wolf P.A., Launer L.J., Lopez O.L., van Duijn C.M., Breteler M.M., CHARGE Consortium, GERAD1 Consortium, EADI1 Consortium Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840.
149. Shinosaki K., Nishikawa T., Takeda M. Neurobiological basis of behavioral and psychological symptoms in dementia of the Alzheimer type. Psychiatry Clin. Neurosci. 2000, 54:611-620.
150. Siegel, J.A., Haley, G.E., Raber, J., 2010. Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice. Neurobiol. Aging, 2010, doi:10.1016/j.neurobiolaging.2010.03.002.
151. Smith G.E., Bohac D.L., Waring S.C., Kokmen E., Tangalos E.G., Ivnik R.J., Petersen R.C. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998, 50:355-362.
152. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljärvi L., Talasniemi S., Ryynänen M., Riekkinen P. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci. Lett. 1995, 187:79-82.
153. Solfrizzi V., Capurso C., D'Introno A., Colacicco A.M., Santamato A., Ranieri M., Fiore P., Capurso A., Panza F. Lifestyle-related factors in predementia and dementia syndromes. Expert Rev. Neurother. 2008, 8:133-158.
154. Spalletta G., Bernardini S., Bellincampi L., Federici G., Trequattrini A., Caltagirone C. Delusion symptoms are associated with APOE e{open}4 allelic variant at the early stage of Alzheimer's disease with late onset. Eur. J. Neurol. 2006, 13:176-182.
155. Srikanth S., Nagaraja A.V., Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J. Neurol. Sci. 2005, 236:43-48.
156. Starkstein S.E., Vázquez S., Petracca G., Sabe L., Migliorelli R., Tesón A., Leiguarda R. A SPECT study of delusions in Alzheimer's disease. Neurology 1994, 44:2055-2059.
157. Starkstein S.E., Sabe L., Vazquez S., Teson A., Petracca G., Chemerinski E., Di Lorenzo G., Leiguarda R. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 1996, 27:408-414.
158. Starkstein S.E., Petracca G., Chemerinski E., Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am. J. Psychiatry 2001, 158:872-877.
159. Starkstein S.E., Jorge R., Petracca G., Robinson R.G. The construct of generalized anxiety disorder in Alzheimer disease. Am. J. Geriatr. Psychiatry 2007, 15:42-49.
160. Steele C., Rovner B., Chase G.A., Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am. J. Psychiatry 1990, 147:1049-1051.
161. Steffens D.C., Plassman B.L., Helms M.J., Welsh-Bohmer K.A., Saunders A.M., Breithner J.C. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol. Psychiatry 1997, 41:851-856.
162. Sultzer D.L., Levin H.S., Mahler M.E., High W.M., Cummings J.L. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am. J. Psychiatry 1993, 150:1806-1812.
163. Swearer J.M., Drachman D.A., O'Donnell B.F., Mitchell A.L. Troublesome and disruptive behaviors in dementia: relationship to diagnosis and disease severity. J. Am. Geriatr. Soc. 1988, 36:784-790.
164. Sweet R.A., Hamilton R.L., Lopez O.L., Klunk W.E., Wisniewski S.R., Kaufer D.I., Healy M.T., DeKosky S.T. Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features. Int. Psychogeriatr. 2000, 12:547-558.
165. Sweet R.A., Nimgaonkar V.L., Devlin B., Lopez O.L., DeKosky S.T. Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 2002, 58:907-911.
166. Sweet R.A., Kamboh M.I., Wisniewski S.R., Lopez O.L., Klunk W.E., Kaufer D.I., DeKosky S.T. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 2002, 15:24-30.
167. Sweet R.A., Nimgaonkar V.L., Devlin B., Jeste D.V. Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype. Mol. Psychiatry 2003, 8:383-392.
168. Tekin S., Mega M.S., Masterman D.M., Chow T., Garakian J., Vinters H.V., Cummings J.L. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann. Neurol. 2001, 49:355-361.
169. Treiber K.A., Lyketsos C.G., Corcoran C., Steinberg M., Norton M., Green R.C., Rabins P., Stein D.M., Welsh-Bohmer K.A., Breitner J.C., Tschanz J.T. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int. Psychogeriatr. 2008, 20:538-553.
170. van Dyck C.H., Gelernter J., MacAvoy M.G., Avery R.A., Criden M., Okereke O., Varma P., Seibyl J.P., Hoffer P.B. The absence of an apolipoprotein E e4 allele is associated with increased parietal rCBF asymmetry in Alzheimer's disease. Arch. Neurol. 1998, 55:1460-1466.
171. van der Flier W.M., Staekenborg S., Pijnenburg Y.A., Gillissen F., Romkes R., Kok A., Bouwman F.H., Scheltens P. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement. Geriatr. Cogn. Disord. 2007, 23:42-46.
172. Weiner M.F., Vega G., Risser R.C., Honig L.S., Cullum C.M., Crumpacker D., Rosenberg R.N. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol. Psychiatry 1999, 45:633-638.
173. Wilson R.S., Barnes L.L., Mendes de Leon C.F., Aggarwal N.T., Schneider J.S., Bach J., Pilat J., Beckett L.A., Arnold S.E., Evans D.A., Bennett D.A. Depressive symptoms, cognitive decline and risk of AD in older persons. Neurology 2002, 59:364-370.
174. Wolitzky-Taylor K.B., Castriotta N., Lenze E.J., Stanley M.A., Craske M.G. Anxiety disorders in older adults: a comprehensive review. Depress. Anxiety 2010, 27:190-211.
175. Woods D.L., Bushnell B., Kim H., Geschwind D., Cummings J. Apolipoprotein epsilon4 status is associated with behavioral symptoms in nursing home residents with dementia. Int. Psychogeriatr. 2009, 21(Suppl. 4):722-728.
176. Wragg R.E., Jeste D.V. Overview of depression and psychosis in Alzheimer's disease. Am. J. Psychiatry 1989, 146:577-589.
177. Yamaguchi H., Sugihara S., Ogawa A., Oshima N., Ihara Y. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects. J. Neuropathol. Exp. Neurol. 2001, 60:731-739.
178. Zdanys K.F., Kleiman T.G., MacAvoy M.G., Black B.T., Rightmer T.E., Grey M., Garman K.S., Tampi R.R., Gelernter J., van Dyck C.H. Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease. Neuropsychopharmacology 2007, 32:171-179.
179. Zubenko G.S., Moossy J., Martinez A.J., Rao G., Claassen D., Rosen J., Kopp U. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch. Neurol. 1991, 48:619-624.